2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
NET
2
Endocrine
2
Conditions
Carcinoma, Non-Small-Cell Lung
74
Breast Neoplasms
70
Rectal Neoplasms
51
Stomach Neoplasms
45
Glioblastoma
45
Esophageal Neoplasms
41
Colorectal Neoplasms
37
Lung Neoplasms
35
Brain Neoplasms
35
Squamous Cell Carcinoma of Head and Neck
32
Pancreatic Neoplasms
31
Glioma
27
Neoplasms
26
Sarcoma
23
Neoplasm Metastasis
23
Astrocytoma
22
Head and Neck Neoplasms
21
Carcinoma, Hepatocellular
18
Esophageal Squamous Cell Carcinoma
16
Colonic Neoplasms
16
Recurrence
15
Ovarian Neoplasms
15
Melanoma
15
Gliosarcoma
15
Central Nervous System Neoplasms
15
Urinary Bladder Neoplasms
13
Oligodendroglioma
13
Uterine Cervical Neoplasms
12
Adenocarcinoma Of Esophagus
12
Prostatic Neoplasms
11
Interventions
lutetium Lu 177 dotatate
40
Everolimus
35
Magnetic Resonance Spectroscopy
15
lanreotide
14
gallium Ga 68 dotatate
13
Temozolomide
13
Octreotide
12
Nivolumab
12
pembrolizumab
11
Capecitabine
11
surufatinib
10
177Lu-octreotide, DOTA(0)-Tyr(3)-
10
cabozantinib
9
Positron Emission Tomography Computed Tomography
9
3-Iodobenzylguanidine
9
Sunitinib
8
Specimen Handling
7
Carboplatin
7
telotristat ethyl
6
pasireotide
6
amino-acid, glucose, and electrolyte solution
6
Somatostatin
6
Lutetium-177
6
90Y-octreotide, DOTA-Tyr(3)-
6
lenvatinib
5
Ipilimumab
5
Ga(III)-DOTATOC
5
Fluorodeoxyglucose F18
5
Etoposide
5
Cisplatin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Surgical Procedures, Operative
×
Clear all
NCT03012789
2024-04-30
NETest_Sx
Wren Laboratories LLC
Phase NA
Active not recruiting
40 enrolled
NCT04066322
2019-09-24
RMPanNET
Fudan University
Unknown
180 enrolled